ANTH
Anthera Pharmaceuticals, Inc.
ANTH
ANTH
Delisted
ANTH was delisted on the 27th of June, 2018.
72 hedge funds and large institutions have $83M invested in Anthera Pharmaceuticals, Inc. in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 28 increasing their positions, 21 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
-14
Holders Change %
-16.28%
% of All Funds
1.92%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
6
Increased
28
Reduced
21
Closed
20
Calls
$357K
Puts
$194K
Net Calls
+$163K
Net Calls Change
-$696K
Top Buyers
1 |
SCM
Sio Capital Management
New York
|
+$6.07M |
2 |
PA
Perceptive Advisors
New York
|
+$1.81M |
3 |
![]()
Franklin Resources
San Mateo,
California
|
+$1.74M |
4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$720K |
5 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$670K |